Norfloxacin + Lactic Acid Bacillus Tablet — Uses

Components & Mechanism of Action

Primary Indications

1. Urinary Tract Infections (UTIs)

• Uncomplicated UTI / acute cystitis in women
• Urethritis
• Norfloxacin was among the first fluoroquinolones specifically approved for lower UTIs; multiple controlled trials confirm efficacy in 3–7 day courses (Recurrent UTI in Adult Women, p. 12)

2. Gastrointestinal Infections / Diarrheal Illness

• Traveler's diarrhea (enterotoxigenic E. coli, Shigella, Salmonella)
• Infectious diarrhea — bacterial gastroenteritis
• The lactic acid bacillus component helps re-establish normal microflora and enhances resistance to reinfection (Diagnosis, Treatment & Prevention of Acute Diarrheal Infections, p. 6)

3. Prevention & Treatment of Antibiotic-Associated Diarrhea

• The probiotic component counters antibiotic-induced dysbiosis
• Lactobacilli inhibit pathogen attachment, modulate the immune response, and assist in restoring colonic flora

4. Other Infections (Norfloxacin component)

• Prostatitis — bacterial (acute and chronic)
• Gonorrhea — uncomplicated urogenital gonorrhoea
• Enteric fever / typhoid (adjunct)

Key Advantages of the Combination

• Norfloxacin alone can cause antibiotic-associated diarrhea and dysbiosis
• Adding Lactic acid bacillus (a spore-forming, acid-resistant Lactobacillus) helps:
  • Maintain gut mucosal integrity
  • Prevent C. difficile overgrowth
  • Shorten duration of antibiotic-associated loose stools
  • Enhance colonization resistance against residual pathogens

Dosing (Typical)

Contraindications

• Hypersensitivity to fluoroquinolones
• Children and adolescents (< 18 years) — risk of arthropathy
• Pregnancy and lactation
• Tendon disorders / history of fluoroquinolone-associated tendinopathy
• Myasthenia gravis
• QT prolongation / concurrent QT-prolonging drugs

Common Side Effects

• Nausea, vomiting, abdominal discomfort
• Headache, dizziness
• Photosensitivity
• Tendinitis / tendon rupture (rare but serious)
• The probiotic component generally reduces GI side effects

Clinical note: Due to rising fluoroquinolone resistance globally, norfloxacin is now reserved for specific indications (especially UTIs and GI infections) in most guidelines. Culture and sensitivity testing is recommended before use when feasible.